chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got the booster shot; Got the booster shot; Nausea; Abdominal discomfort; Fatigue; This is a spontaneous report from a contactable other hcp. A 68-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EW0182, Expiry date: 31Aug2021) via an unspecified route of administration on 20Aug2021 as dose 3, single for COVID-19 immunization. The patient medical history include hypersensitivity from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. Prior to the vaccine, she was on no medication just an Epipen for allergies. She had no health problems no nothing. The patient previously took bnt162b2 (dose 1, Lot number: EL3248) on 21Jan2021 experienced Shingles and Raynaud's, the shingles went away, but the Raynaud's have not and dose 2 (Lot number: EL9266) on 11Feb2021 for COVID-19 immunization.On an unspecified date patient experienced nausea, abdominal discomfort, fatigue. It was reported that patient got the booster shot. The outcome of the event was unknown.  Follow-up (14Sep2021): Follow-up attempts are completed. No further information is expected.
lose consciousness; Dizziness/felt faint; Breathing appeared mildly labored; feeling weird; Tachycardia; Shiver significantly; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of LOSS OF CONSCIOUSNESS (lose consciousness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LOSS OF CONSCIOUSNESS (lose consciousness) (seriousness criterion medically significant), DIZZINESS (Dizziness/felt faint), DYSPNOEA (Breathing appeared mildly labored), FEELING ABNORMAL (feeling weird), TACHYCARDIA (Tachycardia) and CHILLS (Shiver significantly). At the time of the report, LOSS OF CONSCIOUSNESS (lose consciousness), DIZZINESS (Dizziness/felt faint), DYSPNOEA (Breathing appeared mildly labored), FEELING ABNORMAL (feeling weird), TACHYCARDIA (Tachycardia) and CHILLS (Shiver significantly) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On unknown date, during the observation post vaccination, the patient opened the window to the car for air, reported to the nurse that she felt dizzy. The nurse practicioner arrived to the car with emergency supply cart. Patient was reclined in the passenger seat and stated she felt weird and felt. The patient then slumped down and appeared to have lost consciousness for a few seconds. The patient was breathing and began to shivery significantly. Blood pressure within normal limits, she was tachycardic with elevated respirations. At 1237, the nurse practicioner administered 0.3 milligrams intramuscular through the patient's jeans into the right thigh. Patient tolerated it well. Approximately 5 to 10 minutes post epinephrine, patient's vital signs were within normal limits. The patient stated, she felt much better. 911 was called, an ambulance arrived 3 to 4 minutes later. Patient declined to go to the hospital. Patient was driven home by her husband. The doctor called the patient at 1430 and reported being home with no further complaints.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
SORE ARM; LUMP; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th February 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a year after receiving Shingrix, the patient experienced pain in arm and mass. On an unknown date, the outcome of the pain in arm and mass were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and mass to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the right arm. After vaccination with dose of Shingrix, the patient developed a lump on their arm which was present and experienced soreness in the arm once and a while, at the time of reporting. The pharmacist was unsure when these symptoms started following vaccination. The event onset after vaccination with Shingrix was uknown. The batch number and expiry date of Shingrix was unknown. The reporter consented to follow up.
Fever of 102.4 and unresponsive, Sent resident to ER on 11/3/23. resident  readmitted to facility on 11/6/23
I took my pulse ox at around 5 PM the day of the vaccine. My resting heart rate was well over 100, sometimes topping out at 130. It is typically much lower, around 60. It stayed elevated for about 24 hours after my vaccination.   I had flu-like symptoms for about 12 hours which resolved after 24 hours. I also feel I experienced a temporary drop in milk supply while breastfeeding.
Information has been received from a registered nurse concerning a 20 year old female patient with allergy to kiwi unspecified reaction to a topical MYCOSTATIN as a child who on 10-SEP-2009 was vaccinated intramuscular with the first dose of 0.5 ml of GARDASIL (lot # 358271/0558X). Concomitant therapy included "birth control pills". 5 days after vaccination on 15-SEP-2009 the patient experienced a bump at the injection site as big as a half dollar. Around the bump was redness, itchiness and swelling about the size of a woman's hand. The patient did not have any reactions to vaccines as a child. The patient was told to put ice on the area and take BENADRYL and MOTRIN as needed. No laboratory diagnostics study was performed. The patient had sought medical attention by phone. At the time of report, the outcomes of the events were not reported. Additional information has been requested.
severe shingles rash; severe shingles rash; This case was reported by a nurse via sales rep and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 8 days after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient developed severe shingles rash on side/stomach 8 days after receiving 1st dose of shingles. The reporter did not consent to follow up.
About 12 hrs. after shot, violent shaking chills, followed by racing, pounding heart and intense headache, lasting for hours. Chills changed to fever. The racing, pounding heart was the scariest part. All this led to no sleep that night. Next day, headache is still with me, along with exhausting fatigue.
Localized erythema and edema of approx. 6 cm in diameter on L upper arm. The problem is moderate. The lesion of concern is described as red color and growing. Additional information: had shingles vaccine L deltoid 8/11/17, woke up on 8/12/17 with redness, swelling, pain at injection site.  No F/C, difficulty breathing or swallowing, no facial swelling.  No past H/O vaccine reaction.
Cough during night fever, treatment in hospital emergency room of cruise ship. Treated with IV, drugs.
Vaccine given 6/4/09. Pt developed within 24 hours fever, swelling, chills and generalized hives. She was seen on 6/9/09 when a large erythematous area was noted with swelling and tenderness. She had already been seen at clinic and found to have elevated WBC and had been on Augmentin and Bactrim with no response.
17May90 pt vax;  exp itching & eyes became swollen, red, & teary.  Devel increased respiration, dyspnea, rails, & wheezing.  Tx w/ EPI & Benadryl.
high blood pressures 170/63, 165/95; He is feeling like a choking type of feeling on the base of his chest; chest discomfort; Hard for him to swallow; This is a spontaneous report from a contactable consumer (patient's mother). A 12-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 20May2021 18:15 (Batch/Lot Number: EW0168) as 1st dose, single for COVID-19 immunisation. The patient had no relevant medical history and no concomitant medications. No additional vaccines was administered. The first day, the patient was fine but on day second (22May2021), he was feeling like a choking type of feeling on the base of his chest, like in the lower base of his throat. He said that it was hard for him to swallow. He was breathing normally. Patient's mother took his oxygen, he had enough oxygen but he says it felt weird and then he was having high blood pressure. Patient's mother wanted to know if it was normal. The patient experienced high blood pressures and chest discomfort on 22May2021. He has had blood pressures of 170/63. Today, it was 165/95. Events did not require visit to emergency room or physician office. The chest discomfort resolved on 23May2021 however the high blood pressures continue and have remained about the same. Patient's mother stated she does not want to give her son anything because she was not sure about the vaccine. Outcome of chest discomfort was recovered on 23May2021, of high blood pressure was not recovered, of remaining events was unknown.
12/4 10:00pm start 102 fever all night, extreme chills, body aches, nausea,very bad headache in the back of head 12/5 same symptoms except chills.Fever was 99-100.Very bad headache .Arm still sore and lymph node under arm swollen sore 12/6 no fever. Bad body aches and very bad headache.Rash all over back of my head.This started at night.down my neck, on chest, itchy.lymph node still swollen,sore 12/7 Body aches, headache, rash wasn?t as bad but still there and itchy, especially on chest.I went to the doctor to just check to make sure it was ok.Lymph node still a bit sore but not as swollen  12/8 still light rash, got a couple hive looking bumps on right arm. One by my elbow was itchy and red lump.This lump lasted a couple days and then disappeared. 12/9 I was able to go to work.Still had the lump on elbow but not as red and swollen  By  12/10 symptoms gone
LARGE AMOUNT OF SMALL RED BUMPS.  SYMPTOMS STARTED ON FRIDAY JUL, 18 2008
Patient started to get hives around the cheeks of the face within the 15 minutes of waiting after the shot. Patient was advised to take Benadryl to prevent it from further spreading/anaphylaxis.
Swelling, erythema right upper arm developing day of DPT/IPV/MMR given on 09/13/2005. Arm warm to touch, non tender with bruise around site of DTap injection.
Pt reported following adverse events-couldn't raise arm; lg lump (10-12 cm); second finger of left hand numb (could not bend it); pain- level 6; extreme redness; flu like sx; headache; intervals of freezing/fever (100.2). Also admitted to hospital 5 days later for AF possibly related.
Dizziness, Headache, Myalgia, Fever, fever, chills, body aches, headache, dizziness; like flu
Narrative: Patient reported numbness in L arm after receiving his 1st Covid vaccination today. He was in the monitoring area when he reported the numbness. VSS though HR is elevated at 100 an 101 when tested at 12:55 and 13:09. Patient offered water which he declined, states had some caffeine. Patient with intact sensation, numbness at injection site is his only complaint. Patient advised to continue to monitor site up to at least 4 hrs after injection time and seek 911 assistance if trouble breathing, swallowing or swelling, etc. Site is clear, no redness, rash or swelling. Patient discharged saying he was feeling ok.
Gastric Disturbances; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Gastric Disturbances) and DIARRHOEA (Diarrhea) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 091D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jul-2020, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jul-2021, the patient experienced ABDOMINAL DISCOMFORT (Gastric Disturbances) and DIARRHOEA (Diarrhea). At the time of the report, ABDOMINAL DISCOMFORT (Gastric Disturbances) and DIARRHOEA (Diarrhea) had not resolved.            Concomitant product details was not reported.  Treatment details was not reported .   This case was linked to MOD-2021-270691 (Patient Link).
This case was reported by a pharmacist via call center representative and described the occurrence of raised rash in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced raised rash. On an unknown date, the outcome of the raised rash was unknown. It was unknown if the reporter considered the raised rash to be related to SHINGRIX. Additional details were provided as follows: The patient experienced a raised rash underneath the arm. The patient had been referred to their health care provider. The field representative provided very limited information. All questions were asked, no further details were provided.
Information has been received from a consumer concerning his 22 year old female wife who on 16-APR-2008 was vaccinated with the first 0.5 mL dose of GARDASIL (lot # not reported) and on unspecified dates was vaccinated with the second and third 0.5 mL dose of GARDASIL (lot # not reported). The reporter stated that the patient experienced a rash and bruise after her first dose of GARDASIL, and after the third dose the patient was still experiencing abdominal pain, rash, weakness, and flu like symptoms. The patient talked to physician on phone. At the time of reporting, the patient had not recovered. Additional information is not expected.
10/20/2006 administered Pneumovax, 10/30/06 5pm/6pm pt nausea and flaming red, hot raised area below injection site. 10/31/06 3am fever 102F +, 4am 101F+, 10/31/06 1pm MD raised,red area, Thurs 11/02/06 2 1/2x2 in. Wed 11/01/06 4 inch began Claritin, Friday 11/03/06 less redness, heat.
Fevers of 101-102 range and chills daily for 8 consecutive days after receiving vaccine, without any other signs of illness or infection.   Symptoms began 8 hours after receiving vaccine.
Headache 10 mins after shot, muscle spasm in left arm & left shoulder 15 mins after shot, pain lower back, weakness in both legs, aching all over, tired, started about 20 mins after shot, large raised area, red, itch, slight soreness shortly after shot
got swelling in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (got swelling in the arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A, 028L20A and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (got swelling in the arm). At the time of the report, PERIPHERAL SWELLING (got swelling in the arm) outcome was unknown.            Concomitant medications include unspecified diabetic and hypertensive medications. Treatment includes: application of alcohol.
booster; left eye is constantly twitching; my lung is constantly spasm; muscle spasm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2) (Lot number: 070H21H) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "lung surgery" (unspecified if ongoing); "Langerhans cell Histiocytosis" (unspecified if ongoing); "sick" (unspecified if ongoing); "infected and had a severe lung problem" (unspecified if ongoing); "two type of pneumonia" (unspecified if ongoing); "rising of first type of COVID and I have" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE:1, Primary Immunization series complete but unknown manufacturer), for COVID-19 Immunization, reaction(s): "swelling at injection site"; Covid-19 vaccine (Dose 2, Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; MUSCLE TWITCHING (non-serious), outcome "not recovered", described as "left eye is constantly twitching"; MUSCLE SPASMS (non-serious), outcome "not recovered", described as "my lung is constantly spasm; muscle spasm". Therapeutic measures were not taken as a result of muscle twitching, muscle spasms.  Additional Information: The patient had a concern about what happened after she had her booster shot and her son first shot. They think they had the same thing that happened with little bit odd on both. When asked if you both had the shot patient stated, Yes, she have been fully vaccinated with the first booster and her son had his first shot. When asked want to anything about it patient stated, was this normal to all of this sudden like her left eye was constantly twitching or had like muscle spasm in her body. Patient stated, It was also due to the fact that she had the lung surgery right before COVID and she mean, she had been in a breakout and she had her surgery and her lung was constantly spasm. The patient stated, she got sick right before COVID broke out, infected and had a severe lung problem, two type of pneumonia and all this kind of surgery before from the rising of first type of COVID. The patient stated, she had, she was not sure. When probed for any further help patient further stated, no, that was just it, she was just wonder if this was one normal to have like that muscle spasm they know in her body and because her eye or same eye her both of her eye constantly twitching and it has still not stopped.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200036315 Same patient and drug, different event separated in time;US-PFIZER INC-202200036495 Same product and event, different patient
What if a patient gets a third shot?; This case was reported by a consumer via interactive digital media and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st and 2nd dose received on an unknown date).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 24-SEP-2022 Reporter's Comment: This case was reported by the consumer via interactive digital media. The reporter asked what if the patient received third dose of Shingrix vaccine. The reporter wanted to know what if patient gets a third shot. Additional Supportive Information: The patient received a third dose of Shingrix vaccine, which led to extra dose administered.  The follow-up would not possible as no contact details were available.
missed the second dose of the Covid 19 vaccine; Arm hurt; asthma attack; This is a spontaneous report from a contactable pharmacist reported for a male consumer. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on an unspecified date at dose 1, single for covid-19 immunisation. Medical history included severe asthma from an unknown date and unknown if ongoing (Verbatim: severe asthma). Concomitant medications were not reported. On an unspecified date the patient experienced missed the second dose of the covid 19 vaccine, arm hurt, asthma attack. Report 1 of 3. Reporter is a pharmacist calling regarding the Pfizer Covid 19 Vaccine. Reporter stated that she has several patients who have taken the first dose of the vaccine. For different medical reasons, these patients had between 10 and 60 days between the first and requesting the second shot. Reporter has several patients that have missed the second dose of the Covid 19 vaccine. Reporter asking at what point would they restart the series. Do they have to restart the series. Within what period of time. Do they have to do this with Covid. Is there any documentation or literature on this subject. Has one patient who has severe asthma got the first shot and had an attack. This patient is over the age of 65. Stated that he started having an attack and was given a high dose of steroids and was off of them in 10 days. Reporter that none of these patients reported any side effects from the vaccine except their arm hurt. Reporter confirmed she does not have any lot information on her to provide. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021398935 same reporter/drug/AE, different patient
The underarm skin burning of my left arm; Inflammation; The underarm skin burning of my left arm and inflammation that involves the harm and pain; Lack of sleep; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (The underarm skin burning of my left arm), INFLAMMATION (Inflammation), AXILLARY PAIN (The underarm skin burning of my left arm and inflammation that involves the harm and pain) and INSOMNIA (Lack of sleep) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (The underarm skin burning of my left arm), INFLAMMATION (Inflammation), AXILLARY PAIN (The underarm skin burning of my left arm and inflammation that involves the harm and pain) and INSOMNIA (Lack of sleep). At the time of the report, BURNING SENSATION (The underarm skin burning of my left arm), INFLAMMATION (Inflammation), AXILLARY PAIN (The underarm skin burning of my left arm and inflammation that involves the harm and pain) and INSOMNIA (Lack of sleep) had not resolved.            No concomitant medication was reported. It was stated that adverse events impacted the patient for 18 months. The burning  the pain and the lack of sleep was unbearable. Unusual side effects have come to light, including underarm pain as a result of swollen lymph nodes. No treatment medication was reported.